Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes

The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus

(2011) T. Forst et al.   DIABETES OBESITY & METABOLISM

An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future

(2011) S. Madsbad et al.   DIABETES OBESITY & METABOLISM

Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis

(2010) A. Kaas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice

(2010) Takashi Arai et al.   CLINICAL IMMUNOLOGY

Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults

(2010) A. Schölin et al.   DIABETIC MEDICINE

Generation and expansion of regulatory human CD4+ T-cell clones specific for pancreatic islet autoantigens

(2010) James A. Dromey et al.   JOURNAL OF AUTOIMMUNITY

Time for Testing Incretin Therapies in Early Type 1 Diabetes?

(2010) Emanuele Bosi   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin modulation of glucagon secretion: The role of insulin and other factors in the regulation of glucagon secretion

(2010) Dan Kawamori et al.   Islets

Impaired Proinsulin Processing is a Characteristic of Transplanted Islets

(2009) A. M. Klimek et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

(2009) H. B. Mortensen et al.   DIABETES CARE

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis

(2009) Henrik B Mortensen et al.   PEDIATRIC DIABETES

Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database

(2008) R. E. Pratley et al.   DIABETES OBESITY & METABOLISM

Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1

(2008) M Blandino-Rosano et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY